Bristol-Myers Squibb's Thud Heard Round the World - msnbc.com
Bristol-Myers Squibb's Thud Heard Round the World msnbc.com ... on cholesterol drug Lipitor, the best-selling drug in the world, Bristol-Myers has no intentions of trying to market a generic version of the drug on its own, while marketing partner Sanofi has no plans to continue advertising the drug, either.
Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co ... - Sacramento Bee
Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co ... Sacramento Bee By Auxilium Pharmaceuticals, Inc.; GSK MALVERN, Pa. and PHILADELPHIA, May 21, 2012 -- /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) and GlaxoSmithKline LLC, the US subsidiary of GlaxoSmithKline plc (LSE: GSK), announced today that they ...
R&D Trends 2012 - Pharmaceutical Companies use Externalization & Collaboration ... Sacramento Bee With the ongoing patent cliff triggering a wave of patent expiries, pharmaceutical R&D is at a turning point. As a short-term solution to increase profitability, the numerous companies have slashed their budgets, including R&D investment, ...
Oramed Pharmaceuticals to Present at the 11th National Life Science ... - Sacramento Bee
Oramed Pharmaceuticals to Present at the 11th National Life Science ... Sacramento Bee By Oramed Pharmaceuticals Inc. ?Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), a developer of oral delivery systems, announced today that it was chosen to present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference taking place in ...
After OxyContin: Little sign of feared crisis, but abusers adapting to drug's ... - Victoria Times Colonist
After OxyContin: Little sign of feared crisis, but abusers adapting to drug's... Victoria Times Colonist By Sharon Kirkey, Postmedia News May 19, 2012 More than two months after one of the most abused drugs in modern medicine ? OxyContin ? was taken off the market, there are signs that Canadian drug users are trying to adapt and fill the void that's ...
BioDelivery Sciences Receives $2.5 Million Milestone from Meda for BREAKYL in E.U. - Sacramento Bee
BioDelivery Sciences Receives $2.5 Million Milestone from Meda for BREAKYL in E.U. Sacramento Bee BioDelivery Sciences International (NASDAQ: BDSI) is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third ...
Big Pharma's Direct-to-Consumer Advertising Is A Constitutional Right - Independent Voter Network
Big Pharma's Direct-to-Consumer Advertising Is A Constitutional Right Independent Voter Network Yesterday my esteemed colleague, Mike Abrams, wrote a piece recommending a ban on direct-to-consumer pharmaceutical advertising as a remedy for prescription drug abuse in the United States. As will inevitably happen when there is a meeting of ...
New PCMA Ad Campaign: 'It's the Drugstore Lobby vs. Employers' - Sacramento Bee
New PCMA Ad Campaign: 'It's the Drugstore Lobby vs. Employers' Sacramento Bee By Pharmaceutical Care Management Association WASHINGTON, May 7, 2012 /PRNewswire-USNewswire/ -- As drugstore lobbyists descend on Congress to demand higher payments and new restrictions on prescription drug cost cutting, the Pharmaceutical Care ...
Big Pharma's Direct to Consumer Advertising Corrupts America's Health Culture - Independent Voter Network
Big Pharma's Direct to Consumer Advertising Corrupts America's Health Culture Independent Voter Network In the last decade, the United States has seen a massive increase in prescription drug usage and abuse, the cause of which can be traced to irresponsible advertising and lobbying by pharmaceutical companies, collectively known as Big Pharma.
Pharmaceutical Industry Labor-Management Association (PILMA) Statement on ... - Sacramento Bee
Pharmaceutical Industry Labor-Management Association (PILMA) Statement on ... Sacramento Bee By Pharmaceutical Industry Labor-Management Association WASHINGTON, May 17, 2012 -- /PRNewswire-USNewswire/ -- The Pharmaceutical Industry Labor-Management Association (PILMA) today called on members of the Senate to support the swift and streamlined ...
What our clients and candidates are saying about us: I am impressed with your professionalism, directness, and promptness. Even if nothing comes of our communication, it has been a pleasure. - Sharon
The #1 Resource for professionals in the Pharmaceutical Advertising, Medical Communications, Healthcare Public Relations, Pharmaceutical Industry, and Biotechnology fields since 1988.